Food Allergy Market Size, Share, Analysis, Report, Forecast: By Food Source: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soy, Others; By Symptoms: Anaphylaxis, Atopic Dermatitis, Others; By Diagnosis Test: Skin-Prick Tests, Blood Test, Others; By Treatment Type; Regional Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Food Allergy Overview 
    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Food Allergy Epidemiology Analysis – 7MM
    5.1    7MM Epidemiology Scenario Overview (2017-2032)
    5.2    United States Food Allergy Epidemiology Forecast (2017-2032)
    5.3    EU-4 and United Kingdom Food Allergy Epidemiology Forecast (2017-2032)
        5.3.1    Germany Food Allergy Epidemiology Forecast (2017-2032)
        5.3.2    France Food Allergy Epidemiology Forecast (2017-2032)
        5.3.3    Italy Food Allergy Epidemiology Forecast (2017-2032)
        5.3.4    Spain Food Allergy Epidemiology Forecast (2017-2032)
        5.3.5    United Kingdom Food Allergy Epidemiology Forecast (2017-2032)
    5.4    Japan Food Allergy Epidemiology Forecast (2017-2032)
6    Food Allergy Market Overview – 7MM
    6.1    Food Allergy Market Historical Value (2017-2023) 
    6.2    Food Allergy Market Forecast Value (2024-2032)
7    Food Allergy Market Landscape – 7MM
    7.1    Food Allergy Therapeutics Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Food Allergy Therapeutics Product Landscape
        7.2.1    Analysis by Products
        7.2.2    Analysis by Indications
        7.2.3    Analysis by Route of Administration
8    Food Allergy Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Food Allergy Market Dynamics
    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Food Allergy Market Segmentation – 7MM
    11.1    Food Allergy Market by Food Source
        11.1.1    Market Overview
        11.1.2    Dairy Products
        11.1.3    Poultry Product
        11.1.4    Tree Nuts
        11.1.5    Peanuts
        11.1.6    Shellfish
        11.1.7    Wheat
        11.1.8    Soy
        11.1.9    Others
    11.2    Food Allergy Market by Symptoms
        11.2.1    Market Overview
        11.2.2    Anaphylaxis
        11.2.3    Atopic Dermatitis
        11.2.4    Others
    11.3    Food Allergy Market by Diagnosis Test
        11.3.1    Skin-Prick Tests
        11.3.2    Blood Test
        11.3.3    Elimination Diet
        11.3.4    Oral Food Challenge
        11.3.5    Others
    11.4    Food Allergy Market by Treatment Type
        11.4.1    Market Overview
        11.4.2    Epinephrine
        11.4.3    Oral Immunotherapy
        11.4.4    Antihistamines
        11.4.5    Others
    11.5    Food Allergy Market by Region
        11.5.1    Market Overview
        11.5.2    United States
        11.5.3    EU-4 and the United Kingdom
        11.5.3.1    Germany
        11.5.3.2    France
        11.5.3.3    Italy
        11.5.3.4    Spain
        11.5.3.5    United Kingdom 
    11.5.4    Japan
12    United States Food Allergy Market
    12.1    Food Allergy Market Historical Value (2017-2023) 
    12.2    Food Allergy Market Forecast Value (2024-2032)
    12.3    Food Allergy Market by Disease Type
    12.4    Food Allergy Market by Treatment Type
13    EU-4 and United Kingdom Food Allergy Market
    13.1    Food Allergy Market Historical Value (2017-2023) 
    13.2    Food Allergy Market Forecast Value (2024-2032)
    13.3    Germany Food Allergy Market Overview
        13.3.1    Food Allergy Market by Disease Type
        13.3.2    Food Allergy Market by Treatment Type
    13.4    France Food Allergy Market Overview
        13.4.1    Food Allergy Market by Disease Type
        13.4.2    Food Allergy Market by Treatment Type
    13.5    Italy Food Allergy Market Overview
        13.5.1    Food Allergy Market by Disease Type
        13.5.2    Food Allergy Market by Treatment Type
    13.6    Spain Food Allergy Market Overview
        13.6.1    Food Allergy Market by Disease Type
        13.6.2    Food Allergy Market by Treatment Type
    13.7    United Kingdom Food Allergy Market Overview
        13.7.1    Food Allergy Market by Disease Type
        13.7.2    Food Allergy Market by Treatment Type
14    Japan Food Allergy Market
    14.1    Food Allergy Market Historical Value (2017-2023) 
    14.2    Food Allergy Market Forecast Value (2024-2032)
        14.2.1    Food Allergy Market by Disease Type
        14.2.2    Food Allergy Market by Treatment Type
15    Patent Analysis
    15.1    Analysis by Type of Patent
    15.2    Analysis by Publication year
    15.3    Analysis by Issuing Authority
    15.4    Analysis by Patent Age
    15.5    Analysis by CPC Analysis
    15.6    Analysis by Patent Valuation 
    15.7    Analysis by Key Players
16    Grants Analysis
    16.1    Analysis by year
    16.2    Analysis by Amount Awarded
    16.3    Analysis by Issuing Authority
    16.4    Analysis by Grant Application
    16.5    Analysis by Funding Institute
    16.6    Analysis by NIH Departments
    16.7    Analysis by Recipient Organization 
17    Clinical Trials Analysis
    17.1     Analysis by Trial Registration Year
    17.2    Analysis by Trial Status
    17.3    Analysis by Trial Phase
    17.4    Analysis by Therapeutic Area
    17.5    Analysis by Geography
18    Funding Analysis
    18.1    Analysis by Funding Instances
    18.2    Analysis by Type of Funding
    18.3    Analysis by Funding Amount
    18.4    Analysis by Leading Players
    18.5    Analysis by Leading Investors
    18.6    Analysis by Geography
19    Partnership and Collaborations Analysis
    19.1    Analysis by Partnership Instances
    19.2    Analysis by Type of Partnership
    19.3    Analysis by Leading Players
    19.4    Analysis by Geography
20    Supplier Landscape
    20.1    Pfizer Inc.
        20.1.1    Financial Analysis
        20.1.2    Product Portfolio
        20.1.3    Demographic Reach and Achievements
        20.1.4    Mergers and Acquisition
        20.1.5    Certifications
    20.2    GlaxoSmithKline plc
        20.2.1    Financial Analysis
        20.2.2    Product Portfolio
        20.2.3    Demographic Reach and Achievements
        20.2.4    Mergers and Acquisition
        20.2.5    Certifications
    20.3    Novartis AG
        20.3.1    Financial Analysis
        20.3.2    Product Portfolio
        20.3.3    Demographic Reach and Achievements
        20.3.4    Mergers and Acquisition
        20.3.5    Certifications
    20.4    Mylan N.V.
        20.4.1    Financial Analysis
        20.4.2    Product Portfolio
        20.4.3    Demographic Reach and Achievements
        20.4.4    Mergers and Acquisition
        20.4.5    Certifications
    20.5    Teva Pharmaceutical Industries
        20.5.1    Financial Analysis
        20.5.2    Product Portfolio
        20.5.3    Demographic Reach and Achievements
        20.5.4    Mergers and Acquisition
        20.5.5    Certifications
    20.6    Sanofi
        20.6.1    Financial Analysis
        20.6.2    Product Portfolio
        20.6.3    Demographic Reach and Achievements
        20.6.4    Mergers and Acquisition
        20.6.5    Certifications
    20.7    Boehringer Ingelheim International GmbH
        20.7.1    Financial Analysis
        20.7.2    Product Portfolio
        20.7.3    Demographic Reach and Achievements
        20.7.4    Mergers and Acquisition
        20.7.5    Certifications
    20.8    AstraZeneca
        20.8.1    Financial Analysis
        20.8.2    Product Portfolio
        20.8.3    Demographic Reach and Achievements
        20.8.4    Mergers and Acquisition
        20.8.5    Certifications
    20.9    Johnson & Johnson Private Limited
        20.9.1    Financial Analysis
        20.9.2    Product Portfolio
        20.9.3    Demographic Reach and Achievements
        20.9.4    Mergers and Acquisition
        20.9.5    Certifications
    20.10    Bayer AG
        20.10.1    Financial Analysis
        20.10.2    Product Portfolio
        20.10.3    Demographic Reach and Achievements
        20.10.4    Mergers and Acquisition
        20.10.5    Certifications
21    Food Allergy Market - Distribution Model (Additional Insight)
    21.1    Overview 
    21.2    Potential Distributors 
    21.3    Key Parameters for Distribution Partner Assessment 
22    Key Opinion Leaders (KOL) Insights (Additional Insight)
23    Company Competitiveness Analysis (Additional Insight)
    23.1    Very Small Companies
    23.2    Small Companies
    23.3    Mid-Sized Companies
    23.4    Large Companies
    23.5    Very Large Companies
24    Payment Methods (Additional Insight)
    24.1    Government Funded
    24.2    Private Insurance
    24.3    Out-of-Pocket

*Additional insights provided are customisable as per client requirements.